These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11048889)

  • 1. Phospholipase A2 and small, dense low-density lipoprotein.
    Hurt-Camejo E; Camejo G; Sartipy P
    Curr Opin Lipidol; 2000 Oct; 11(5):465-71. PubMed ID: 11048889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis: possible contribution of phospholipase A2 to this atherogenic profile.
    Hurt-Camejo E; Paredes S; Masana L; Camejo G; Sartipy P; Rosengren B; Pedreno J; Vallve JC; Benito P; Wiklund O
    Arthritis Rheum; 2001 Dec; 44(12):2761-7. PubMed ID: 11762936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase A(2) modification of low density lipoproteins forms small high density particles with increased affinity for proteoglycans and glycosaminoglycans.
    Sartipy P; Camejo G; Svensson L; Hurt-Camejo E
    J Biol Chem; 1999 Sep; 274(36):25913-20. PubMed ID: 10464335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism for changes in proteoglycan binding on compositional changes of the core and the surface of low-density lipoprotein-containing human apolipoprotein B100.
    Flood C; Gustafsson M; Pitas RE; Arnaboldi L; Walzem RL; Borén J
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):564-70. PubMed ID: 14726411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent modification of low density lipoprotein by group X secretory phospholipase A2 is linked to macrophage foam cell formation.
    Hanasaki K; Yamada K; Yamamoto S; Ishimoto Y; Saiga A; Ono T; Ikeda M; Notoya M; Kamitani S; Arita H
    J Biol Chem; 2002 Aug; 277(32):29116-24. PubMed ID: 12021277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.
    Chapman MJ; Guérin M; Bruckert E
    Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
    Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
    Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans.
    Oörni K; Posio P; Ala-Korpela M; Jauhiainen M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1678-83. PubMed ID: 15879301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein atherogenicity: an overview of current mechanisms.
    Griffin BA
    Proc Nutr Soc; 1999 Feb; 58(1):163-9. PubMed ID: 10343354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The catalytically active secretory phospholipase A2 type IIA is involved in restenosis development after PTCA in human coronary arteries and generation of atherogenic LDL.
    Korotaeva AA; Samoilova EV; Kaminny AI; Pirkova AA; Resink TJ; Erne P; Prokazova NV; Tkachuk VA; Chazov EI
    Mol Cell Biochem; 2005 Feb; 270(1-2):107-13. PubMed ID: 15792359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherogenic lipoprotein particles in atherosclerosis.
    Carmena R; Duriez P; Fruchart JC
    Circulation; 2004 Jun; 109(23 Suppl 1):III2-7. PubMed ID: 15198959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation.
    Wooton-Kee CR; Boyanovsky BB; Nasser MS; de Villiers WJ; Webb NR
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):762-7. PubMed ID: 14962950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The small, dense LDL phenotype as a correlate of postprandial lipemia in men.
    Lemieux I; Couillard C; Pascot A; Bergeron N; Prud'homme D; Bergeron J; Tremblay A; Bouchard C; Mauriège P; Després JP
    Atherosclerosis; 2000 Dec; 153(2):423-32. PubMed ID: 11164432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.
    Kwiterovich PO
    Am J Cardiol; 2002 Oct; 90(8A):30i-47i. PubMed ID: 12419479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tagging SNP haplotype analysis of the secretory PLA2-V gene, PLA2G5, shows strong association with LDL and oxLDL levels, suggesting functional distinction from sPLA2-IIA: results from the UDACS study.
    Wootton PT; Arora NL; Drenos F; Thompson SR; Cooper JA; Stephens JW; Hurel SJ; Hurt-Camejo E; Wiklund O; Humphries SE; Talmud PJ
    Hum Mol Genet; 2007 Jun; 16(12):1437-44. PubMed ID: 17545304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingomyelinase induces aggregation and fusion, but phospholipase A2 only aggregation, of low density lipoprotein (LDL) particles. Two distinct mechanisms leading to increased binding strength of LDL to human aortic proteoglycans.
    Oörni K; Hakala JK; Annila A; Ala-Korpela M; Kovanen PT
    J Biol Chem; 1998 Oct; 273(44):29127-34. PubMed ID: 9786921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density lipoprotein modification occurring in human plasma possible mechanism of in vivo lipoprotein desialylation as a primary step of atherogenic modification.
    Tertov VV; Kaplun VV; Sobenin IA; Orekhov AN
    Atherosclerosis; 1998 May; 138(1):183-95. PubMed ID: 9678784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma.
    Gazi I; Lourida ES; Filippatos T; Tsimihodimos V; Elisaf M; Tselepis AD
    Clin Chem; 2005 Dec; 51(12):2264-73. PubMed ID: 16223884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipolysis of LDL by human secretory phospholipase A(2) induces particle fusion and enhances the retention of LDL to human aortic proteoglycans.
    Hakala JK; Oörni K; Pentikäinen MO; Hurt-Camejo E; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1053-8. PubMed ID: 11397719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of mild to moderately elevated triglycerides on low density lipoprotein subfraction concentration and composition in healthy men with low high density lipoprotein cholesterol levels.
    Halle M; Berg A; Baumstark MW; König D; Huonker M; Keul Joseph
    Atherosclerosis; 1999 Mar; 143(1):185-92. PubMed ID: 10208494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.